Quality of life after breast cancer surgery with or without supportive oncology care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study following women with histologically confirmed invasive breast cancer who are scheduled for surgery to compare quality-of-life outcomes according to their access to supportive oncological care inside or outside the treatment center. Participants complete validated quality-of-life questionnaires at defined points during their care pathway to capture physical, emotional, and social wellbeing. Researchers will compare questionnaire results between patients with differing levels or timing of supportive care to identify associations. The study is conducted at participating French hospitals and requires participants to speak French and be able to complete written questionnaires.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Woman with histologically confirmed invasive breast cancer for whom surgery is scheduled
* Age\> 18 years old
* Performance status ECOG \<2
* Patient speaking and understanding French and able to complete questionnaires
* Patient affiliated or beneficiary of a social security scheme
* Patient having read the information note and not objecting to the use of the data collected

Exclusion Criteria:

* male
* Patient with metastatic breast cancer
* Patient with bilateral breast cancer
* History of cancer of less than 5 years
* Active infection or other serious underlying condition that may prevent the patient from receiving treatment
* History or progressive psychiatric illness
* Person deprived of liberty or under guardianship
* Inability to undergo medical monitoring for geographical, social or psychological reasons Indication of emergency amputation
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
* Pregnant, breastfeeding or parturient woman
* Patient hospitalized without consent

Where it's running

• Institut du sein Drôme Ardèche
  Guilherand-Granges, France Recruiting
• Hôpital Privé de l'Estuaire
  Le Havre, France Recruiting

Study contacts

• Study coordinator: Jean-François Oudet
• Email: jf.oudet@ecten.eu
• Phone: 0683346567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oncoliq blood test for early detection of breast cancer

  This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.

  Recruiting Oncoliq US Inc · Buenos Aires, Buenos Aires · NCT07331506

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• Negative pressure wound therapy after mastectomy

  This study tests whether a negative pressure dressing after mastectomy reduces fluid build‑up and common wound complications in women with breast cancer.

  Recruiting Dalarna County Council, Sweden · Falun · NCT07607366

• ATUSA 3D automated breast ultrasound for suspicious breast lesions

  This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.

  Recruiting at 2 sites iSono Health, Inc. · Sacramento, California and 1 other locations · NCT07505797

• Support tool for women with HR+ breast cancer on long-term endocrine therapy

  This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07482384

• Conformal ablative radiotherapy for older women with localized ER-positive, HER2-negative breast cancer choosing non-surgical care

  This study will test whether five focused SABR treatments can control ER-positive, HER2-negative breast tumors up to 5 cm in women aged 65 and older who are opting for non-surgical management.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas and 1 other locations · NCT07242118

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.